RxDoctor Payments Data

Elizabeth Larew, NP

Family · Harrogate, TNNPI 1427191725

Payments from drug & device makers

$4,918in general payments, 2019–2025

Across 303 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$965
  • AbbVie$711
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$470
  • Pfizer$238
  • Astellas Pharma US Inc$236
  • Sumitomo Pharma America, Inc.$200
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$4,72996%
  • Education$1894%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,918 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$112,141
Medicare patients
323
Services billed
7,025

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide179$206,403
EliquisApixaban159$149,669
OzempicSemaglutide133$128,594
Plegridy PenPeginterferon Beta-1a13$109,438
LinzessLinaclotide85$86,611
RybelsusSemaglutide53$72,390
VraylarCariprazine Hcl45$65,928
Nurtec OdtRimegepant Sulfate40$58,434
Trelegy ElliptaFluticasone/Umeclidin/Vilanter65$55,686
JanuviaSitagliptin Phosphate48$54,677
TrulicityDulaglutide37$48,303
JardianceEmpagliflozin46$47,139
RexultiBrexpiprazole32$46,508
Breztri AerosphereBudesonide/Glycopyr/Formoterol56$42,776
Trijardy XrEmpaglifloz/Linaglip/Metformin31$39,333

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$82$254,706216 claims
PfizerEliquis, Nurtec Odt$238$208,103199 claims
Novo NordiskOzempic, Rybelsus$965$200,983186 claims
AbbVieLinzess, Vraylar, Qulipta, Botox$711$186,310155 claims
Boehringer IngelheimJardiance, Trijardy Xr, Tradjenta, Glyxambi, Spiriva Respimat$75$163,168170 claims
MerckJanuvia, Janumet Xr, Belsomra$17$101,486118 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$124$94,324131 claims
GSKTrelegy Ellipta, Breo Ellipta$192$70,92081 claims
Otsuka America Pharmaceutical, Inc.Rexulti$121$46,50832 claims
Astellas Pharma US IncMyrbetriq$236$38,34439 claims
AmgenProlia$48$35,92121 claims
Johnson & JohnsonXarelto$18$25,73026 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,706 family providers in Tennessee.

Other family in Harrogate

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →